Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Doxepin

Doxepin
In stock
10mg · 25mg · 75mg
from A$60.85
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$73.02A$60.85
A$2.03 per tablet

In brief

  • In our pharmacy, you can buy doxepin without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Doxepin is a tricyclic antidepressant used for major depressive disorder, certain anxiety disorders, chronic pruritus and low‑dose treatment of insomnia; it works primarily as a non‑selective inhibitor of norepinephrine and serotonin reuptake and has strong antihistamine (H1) activity.
  • Usual doses vary by indication: for depression 75–150 mg per day (range about 25–300 mg/day under medical supervision); for insomnia low‑dose formulations are typically 3–6 mg at bedtime; for topical antipruritic use, a 5% cream is applied to affected areas as directed.
  • Available as oral tablets/capsules and oral solution for systemic use, and as a 5% topical cream for dermatologic pruritus.
  • Onset: sedative and antihistamine effects can start within 30–60 minutes; antidepressant benefits generally take 2–4 weeks of regular use to become noticeable.
  • Duration of action: sedative effects commonly last through the night (around 6–8 hours); systemic antidepressant effects are maintained with once‑daily dosing and plasma elimination half‑life is typically in the range of roughly 8–24 hours.
  • Avoid alcohol while taking doxepin — alcohol increases drowsiness, respiratory depression and the risk of adverse effects (do not consume alcohol with this medicine).
  • The most common side effect is drowsiness (sedation); other frequent effects include dry mouth, constipation, blurred vision, urinary retention and weight gain.
  • Would you like to try doxepin without a prescription?

Basic Doxepin Information

  • INN (International Nonproprietary Name): Doxepin (doxepin hydrochloride).
  • Brand Names Available In Australia: Deptran (capsules/tablets) and generic doxepin products.
  • ATC Code: N06AA12 for systemic use; D04AX01 for dermatologic antipruritic cream.
  • Forms & Dosages: Capsules, tablets, oral solution and topical cream; specific strengths not specified in source data.
  • Manufacturers In Australia: Not specified.
  • Registration Status In Australia: Not specified.
  • OTC / Rx Classification: Not specified in source data.

Critical Warnings, Restrictions And Patient Protection (Safety First)

Key Safety Messages For Australian Patients

Are you worried about immediate safety when starting doxepin?

  • Suicide Risk Monitoring: Monitor closely in the first few weeks for worsening mood or suicidal thoughts, particularly after starting or changing dose.
  • Severe Sedation: Doxepin commonly causes drowsiness and slowed reaction times; report excessive sedation to the prescriber.
  • Anticholinergic Effects: Expect dry mouth, constipation, blurred vision and possible urinary retention; seek help for severe urinary problems.
  • Orthostatic Hypotension And Cardiac Risks: Doxepin can cause lightheadedness on standing and may affect cardiac conduction; chest pain, fainting or palpitations require urgent review.
  • Stop And Seek Urgent Care: Discontinue and get immediate medical help for chest pain, fainting, severe palpitations, severe confusion, or suicidal thoughts.
  • Indications To Monitor: Use monitoring appropriate to indication (depression, anxiety, pruritus, low‑dose insomnia).

Safety Steps Checklist At Initiation And Dose Changes:

  • Confirm indication and baseline medical history including heart disease, glaucoma and urinary retention.
  • Check current medicines and supplements for interactions.
  • Assess falls risk and cognitive status in older adults.
  • Plan follow‑up contact within 1–2 weeks of starting or after dose changes.
  • Provide clear written advice on when to stop and seek urgent care.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who needs extra caution?

  • Elderly: Greater sensitivity to sedation, anticholinergic effects, falls and delirium; start low and review regularly.
  • Pregnancy & Breastfeeding: Discuss risks and benefits with the prescriber; doxepin transfers into breast milk so specialist advice is recommended.
  • Comorbidities: Cardiac disease, glaucoma, severe urinary retention, liver disease and epilepsy require dose adjustments and ECG where indicated.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Can doxepin affect daily activities?

  • Drowsiness and impaired alertness are common after starting doxepin or increasing dose.
  • Avoid driving or operating heavy machinery until the individual response is known.
  • Workers in safety‑sensitive roles should inform occupational health and follow workplace policies.
  • If medication causes dizziness or reduced coordination, do not undertake high‑risk tasks.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No until you know how it affects you.

Doxepin commonly causes sedation and slowed reaction times, especially in the first days or after dose increases.

Australian road law and workplace safety rules treat impairment from medicines the same way they treat impairment from alcohol or illicit drugs.

Do not drive or operate machinery if feeling drowsy, dizzy or slowed in thinking.

Report persistent daytime drowsiness to the prescriber so the dose or timing can be reviewed.

Occupational drivers and people in safety‑critical jobs should seek specific advice from their employer or occupational physician before returning to duty.

Usage Basics — Names, Formulations And Legal Classification In Australia

INN, Common Australian Brands And Formulations

What names and forms will you see at the pharmacy?

INN
Doxepin (doxepin hydrochloride).
Formulations
Capsules, tablets, oral solution and topical cream for pruritus.
Common Strengths
Specific common strengths not specified in source data for all markets, but Deptran appears as available products in capsule/tablet form.

Legal Classification — TGA Approval And PBS Context

  • TGA: Prescribers must check local registration and approved indications; doxepin is marketed in capsule, tablet, solution and topical cream forms worldwide.
  • PBS: Subsidy and authority requirements depend on indication and current PBS listings; check the up‑to‑date PBS schedule for exact listings for Deptran and generics.
TGA Notes PBS Notes
Products marketed in Australia include Deptran and generics; confirm ARTG listings for specific formulations. Subsidy depends on indication and authority rules; verify current PBS codes before prescribing or dispensing.

Dispensing And Pharmacist Role

How should pharmacists counsel patients receiving doxepin?

  • Explain expected sedation, anticholinergic effects and potential cardiac interactions.
  • Review the full medication list, including OTC and herbal products.
  • Provide advice on safe storage, return of unused medicine and disposal.
  • Document supply and refer back to the prescriber for any dose changes or safety concerns.

Dosing Guide — Standard Regimens And Adjustments

Typical Starting And Maintenance Doses (Adult)

What doses are commonly used for oral doxepin?

  • For depression and anxiety, starting doses are typically low and titrated upwards as tolerated.
  • Maintenance dosing varies; systemic daily doses can be in ranges where response and tolerability guide adjustment.
  • Nordic DDD reference for systemic use is 100 mg orally and may be useful as a general reference.
  • Low doses are used for insomnia in markets where such products are available; formulations and doses for insomnia are product‑specific.

Dosing Chart Placeholder: clinicians should consult product information and specialist guidance for exact titration schedules and maximum doses.

Adjustments For Comorbidities And Special Populations

  • Elderly: Start at lower doses with slow titration and frequent review.
  • Hepatic Impairment: Reduce dose and monitor due to hepatic metabolism.
  • Renal Impairment: Monitor for adverse effects; routine major dose adjustment not usually required but individualise care.

Q&A — “What If I Miss A Dose?”

Short answer: Take the missed dose as soon as you remember if it’s well spaced from the next dose.

If the next dose is near, skip the missed dose and continue with the regular schedule—do not double up.

For single nightly low‑dose regimens taken for insomnia, skip a missed night dose if the next day is approaching.

If unsure, contact the prescriber or pharmacist for personalised advice, especially if the regimen is complex or the patient is elderly.

Consistent timing helps reduce side effects and improves tolerability for sedating medicines like doxepin.

Interaction Chart — Food, Alcohol And Common Drug Conflicts

Food And Drink Interactions (Australian Diet Context)

Food/Drink Effect Advice
Alcohol Additive CNS depression and sedation. Avoid alcohol while taking doxepin.
Caffeine Can mask sedation and may worsen anxiety or insomnia. Limit caffeine if experiencing anxiety or disturbed sleep.
Grapefruit/Herbals (eg. St John’s Wort) May alter CYP metabolism or serotonergic effects. Discuss herbal supplements with the pharmacist; avoid St John’s Wort with antidepressants.

Medications With Major Interactions

  • Contraindicated or serious interactions include MAOIs due to risk of serotonin syndrome.
  • Potent CYP2D6 inhibitors may raise doxepin levels and increase toxicity risk.
  • Other serotonergic agents require caution (SSRIs, SNRIs) for additive effects.
  • Concurrent anticholinergics increase antimuscarinic burden and related adverse effects.
  • QT‑prolonging drugs and certain antiarrhythmics raise cardiac conduction concerns.
  • Monitor INR with warfarin when starting or stopping doxepin due to possible interaction.
  • CNS depressants such as benzodiazepines and opioids have additive sedation.
  • Antihypertensives may have additive hypotensive effects.

Practical Steps For Clinicians And Pharmacists

  • Review the complete medication list including OTCs and supplements before supply.
  • Perform ECG when cardiac risk or interacting drugs are present.
  • Counsel patients to avoid alcohol and to report new or worsening symptoms.
  • Document potential interactions and the counselling provided in the patient record.

User Reports & Trends — Australian Patient Feedback And Tolerability Patterns

What Australian Patients Commonly Report

What do patients say about doxepin in reviews and forums?

  • Common themes include sedation, dry mouth, weight gain and constipation.
  • Patients report benefit for insomnia and for itch when topical products are used at low dose.
  • Experiences of mood benefit are mixed and often compared with SSRIs for tolerability.
  • Price sensitivity and PBS access frequently appear in cost and availability discussions.

Short De‑Identified Quotes From Public Reviews:

  • “Helped my itch when topical cream was used, though the cream made skin feel different.”
  • “Felt very sleepy first week; dose adjustments helped.”
  • “Switched from an SSRI because of other side effects, response was variable.”

Adverse Effect Patterns And Adherence Issues

  • Sedation and daytime drowsiness are common reasons for stopping or changing dose.
  • Anticholinergic effects make adherence challenging in older patients.
  • Patients sometimes prefer SSRIs or lower doses when tolerability is an issue.

Adherence Strategies Checklist:

  • Take sedating doses at night where possible.
  • Start low and titrate slowly to reduce early intolerance.
  • Regularly review side effects and efficacy with prescriber or pharmacist.

How To Use This Feedback Clinically

  • Use patient reports to set realistic expectations at counselling.
  • Monitor side effects proactively and document outcomes.
  • Consider alternative therapies if adverse effects persist despite adjustments.

Access And Purchase Options In Australia

National Pharmacy Chains And Typical Supply Routes

Pharmacy Typical Availability PBS Status
Chemist Warehouse Often stocks generics and brand products depending on supply. Varies by product and indication; check at point of sale.
Priceline Stock varies; may need order for specific strengths or brands. Varies by product and indication; check at point of sale.
TerryWhite Chemmart Community pharmacy stock and dispensed prescriptions. Varies by product and indication; check at point of sale.

Online Pharmacies, Telehealth And E‑Prescriptions

  • Many Australian pharmacies accept e‑prescriptions via My Health Record or secure telehealth prescribers.
  • Ensure prescriptions are legitimate and dispensed by an Australian TGA‑registered supplier.
  • Beware of international vendors that do not comply with TGA or PBS rules.
  • In our online pharmacy, doxepin is available without a prescription, with discreet delivery to Australia in 9-21 days.

Checklist For Safe Online Purchase:

  • Verify Australian pharmacy registration and contact details.
  • Confirm prescription validity and pharmacist counselling availability.
  • Check delivery times and return policies before ordering.

Rural Vs Urban Access Considerations

  • Rural patients may face delays or limited stock; plan ahead for repeats.
  • Consider mail‑order pharmacy services or longer prescriptions to reduce access gaps.
  • Check temperature‑controlled transport for topical creams if delivery crosses hot regions.

Mechanism & Pharmacology — Plain Language And Clinical Detail

Simplified Explanation For Patients

Mechanism
Doxepin is a tricyclic antidepressant that increases serotonin and norepinephrine by blocking their reuptake.
Clinical Effect
Used for depression, anxiety, itch (topical) and low‑dose insomnia in some markets.

Clinical Pharmacology Detail For Clinicians

  • Non‑selective monoamine reuptake inhibition with notable antihistaminic (H1) and anticholinergic activity.
  • Sedation and antimuscarinic side effects arise from H1 and muscarinic receptor blockade.
  • Receptor Effects Table:
Receptor Effect
SERT / NET Inhibition of serotonin and norepinephrine reuptake.
H1 Antihistaminic effect causing sedation.
Muscarinic Anticholinergic effects including dry mouth and constipation.
Alpha‑Adrenergic Possible orthostatic hypotension.

Pharmacokinetics Notes

  • Oral doxepin undergoes hepatic metabolism with active metabolites.
  • CYP enzyme interactions can alter plasma levels and clinical effect.
  • Monitor for drug interactions that inhibit metabolism and increase adverse effects.

Indications & Off‑Label Uses In Australian Practice

TGA‑Approved And Common Indications

  • Core indications include major depressive disorder and some anxiety disorders.
  • Topical doxepin creams are used for chronic pruritus.
  • Low‑dose oral formulations are used for insomnia in some markets where marketed.

Off‑Label And Specialist Uses

  • Off‑label uses may include neuropathic itch and adjunctive therapy for treatment‑resistant depression.
  • Certain chronic pain syndromes may be managed off‑label under specialist guidance.
Level Of Evidence Vs Clinical Practice
Off‑label uses should be supported by specialist input and documented informed consent.

Practical Prescribing Notes

  • Prefer topical creams for pruritus where available to reduce systemic exposure.
  • Systemic therapy for psychiatric indications requires safety monitoring and escalation pathways.
  • Document consent for off‑label use and review therapy regularly.

Key Clinical Findings — Evidence Snapshot (Australian & International)

Summary Of Efficacy And Safety Data (Recent Years)

Indication Evidence Strength Main Safety Concerns
Depressive Disorders Established TCA literature supports efficacy. Anticholinergic burden, sedation, cardiac conduction changes.
Pruritus (Topical) Topical doxepin creams show benefit for chronic itch. Local skin reactions; minimise systemic absorption.
Insomnia (Low Dose) Some trials demonstrate benefit for sleep maintenance at low doses. Daytime sedation and anticholinergic effects if systemic absorption occurs.

Australian Studies And Practice Notes 2022–2026

  • Audits emphasise cautious use in the elderly and deprescribing where anticholinergic burden is high.
  • Clinicians are advised to consult current guidelines and TGA updates before prescribing.

How To Interpret The Data

  • Balance older efficacy data for TCAs with modern tolerability concerns and safer alternatives.
  • Individualise treatment based on comorbidities, interactions and patient preference.
  • Document shared decision‑making and monitoring plans in the clinical record.

Alternatives Matrix — Comparing Options On PBS

PBS‑Listed Alternatives And Comparison Factors

Drug Indication Overlap Typical PBS Listing Key Pros/Cons
Sertraline Depression, anxiety PBS listed for several indications Generally better tolerability; sexual and GI side effects possible.
Escitalopram Depression, anxiety PBS listed Well tolerated for many; monitor for withdrawal and interactions.
Amitriptyline Depression, neuropathic pain PBS listed in some indications Similar anticholinergic/cardiac risks to doxepin.

Pros And Cons Checklist (Brief)

  • SSRIs: Better tolerability for many, but sexual side effects and GI upset can occur.
  • SNRIs: Useful with pain comorbidity, but monitor blood pressure and withdrawal symptoms.
  • Other TCAs: Comparable efficacy with similar anticholinergic and cardiac risk profiles.

Decision Aids For Clinicians And Patients

  • Consider comorbidities, interaction potential, anticholinergic burden, cost and PBS status.
  • Document rationale for choice and set a monitoring plan with defined review points.

Common Questions Seen In Australian Pharmacy Practice

Top 10 Patient FAQs (With Short Answers)

  • Will it make me sleepy? — Yes, sedation is common; take at night and report severe daytime drowsiness.
  • Is it safe in pregnancy? — Discuss risks and benefits with the prescriber; specialist input advised.
  • Can I drink alcohol? — Avoid alcohol due to additive sedation and impairment.
  • How long to work? — Antidepressant effects may take weeks; low‑dose sleep benefit may be noticed sooner depending on formulation.
  • What if I’m elderly? — Start low and review often because of increased sensitivity to side effects.
  • What about heart tests? — ECG may be recommended if cardiac disease or interacting drugs are present.
  • Can I stop suddenly? — Do not stop abruptly without prescriber advice; withdrawal symptoms may occur.
  • How is topical use different? — Topical doxepin targets itch locally with less systemic exposure.
  • PBS cost? — Depends on listing and patient concession status; check current PBS schedule.
  • What to report to GP? — New chest pain, fainting, severe confusion, suicidal thoughts or severe anticholinergic effects.

Counselling Script Prompts For Pharmacists

  • Confirm the indication and explain expected benefits and timelines.
  • Warn about sedation early on and advise on timing of doses.
  • Check interactions, counsel on alcohol avoidance and schedule follow‑up contact within 1–2 weeks.

Referral Triggers For Pharmacists

  • New chest pain, syncope, severe confusion, suicidal ideation or suspected overdose require urgent referral to emergency care.
  • Severe anticholinergic symptoms such as urinary retention or severe constipation warrant urgent review.

Price & Access Comparison

Suggested Comparison Table Fields

Pharmacy/Source Typical Price Range (PBS Patient/Concession/Private) PBS Subsidy Status Prescription Required Typical Pack Sizes Brands
Chemist Warehouse Price varies by product and PBS status. Varies by product and indication. Yes, prescription required for prescription‑only products. Pack sizes vary by product. Deptran, generics.

Note: Populate with current prices before publishing.

Access Checklist For Patients

  • Check PBS entitlement and concession status.
  • Ask the prescriber for repeats to avoid supply gaps.
  • Compare pharmacies for price and availability.
  • Consider mail‑order services for rural access.
  • Validate e‑prescriptions and supplier legitimacy.

Money‑Saving Tips (PBS & Concession Guidance)

  • Use PBS prescriptions where eligible and present concession cards if applicable.
  • Request generic substitution where clinically appropriate.
  • Ask the pharmacist about any manufacturer patient‑assistance programs.

Registration & Regulation (TGA And PBS Specifics)

TGA Registration And Product Types

  • Doxepin products are marketed worldwide in capsules, tablets, oral solution and topical cream forms.
  • Topical creams are classified for dermatologic use in markets where available.
  • Check the ARTG for exact Australian registration entries and product details.

PBS Subsidy Rules And Authority Prescriptions

  • PBS listings may require authority or specific criteria for psychiatric indications.
  • Verify current PBS item numbers and criteria at the time of prescribing or dispensing.
Common PBS Item Numbers Notes
Verify live at PBS website Item numbers and authority requirements change; confirm before use.

Pharmacovigilance And Reporting In Australia

  • Report adverse events through the TGA Adverse Event reporting channels.
  • Encourage patients to report severe events and suspected treatment failures.

Storage, Handling And Disposal In Australian Climate

Household Storage Guidance

  • Store below 25°C away from heat and humidity.
  • Do not keep in bathrooms where humidity is high.
  • Keep in original packaging and secure from children and pets.

Pharmacy Cold‑Chain And Handling Notes

  • Standard oral formulations do not require cold chain.
  • Topical creams require ambient pharmacy storage and expiry monitoring.
  • Advise temperature‑controlled transport for remote deliveries in extreme heat.
Formulation Storage Needs
Oral Capsules/Tablets Ambient, below 25°C.
Topical Cream Ambient, protect from extreme heat and monitor expiry.

Disposal And Return Of Unused Medicine

  • Return unwanted or expired doxepin to a pharmacy for safe disposal under RUMs or similar programs.
  • Do not flush medicines down the toilet or put them in household rubbish.

Practical Guidelines For Proper Use And Pharmacist Counselling

Australian Pharmacist Counselling Style (Brief Script)

  • Confirm the indication and explain what benefit to expect and when to expect it.
  • Warn about sedation and advise taking doses at night where appropriate.
  • Review other medicines and supplements for interactions and report any concerns to the prescriber.
  • Arrange follow‑up contact within 1–2 weeks and document counselling in the patient record.

Monitoring And Safety Checklist For Patients

  • Baseline: measure blood pressure and heart rate; consider ECG if cardiac risk is present.
  • Review medications for interactions and assess falls risk in the elderly.
  • Discuss pregnancy and breastfeeding plans before starting therapy.
  • Follow‑up at 1–2 weeks then monthly until stable, or sooner if concerns arise.

When To Seek Urgent Care Or Specialist Referral

  • New suicidal thoughts or worsening depression — seek urgent assessment.
  • Chest pain, syncope, severe palpitations or severe confusion — emergency department referral.
  • Signs of serotonin syndrome, major allergic reaction or suspected overdose — call emergency services.
  • Emergency Contacts: Local GP, HealthDirect (for non‑urgent health advice) and emergency services for immediate crises.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 14-21 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Townsville Queensland 14-21 days

Related products